Colgate-Palmolive (NYSE:CL) Shares Acquired by HHM Wealth Advisors LLC

HHM Wealth Advisors LLC lifted its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 24.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,136 shares of the company’s stock after purchasing an additional 226 shares during the period. HHM Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $103,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CL. State Street Corp lifted its position in shares of Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock worth $2,095,325,000 after buying an additional 552,949 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after purchasing an additional 557,492 shares during the period. Barclays PLC grew its stake in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Finally, FMR LLC grew its position in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CL. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Barclays reduced their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $101.16.

View Our Latest Analysis on CL

Colgate-Palmolive Stock Up 0.4 %

Shares of Colgate-Palmolive stock opened at $87.05 on Tuesday. The company has a market capitalization of $71.12 billion, a P/E ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The business has a 50-day moving average of $91.35 and a two-hundred day moving average of $97.15.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the company earned $0.87 earnings per share. As a group, equities analysts predict that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.